• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用离子载体莫能菌素A对丙型肝炎病毒进入及细胞间传播的新认识

New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.

作者信息

Fénéant Lucie, Potel Julie, François Catherine, Sané Famara, Douam Florian, Belouzard Sandrine, Calland Noémie, Vausselin Thibaut, Rouillé Yves, Descamps Véronique, Baumert Thomas F, Duverlie Gilles, Lavillette Dimitri, Hober Didier, Dubuisson Jean, Wychowski Czeslaw, Cocquerel Laurence

机构信息

Molecular and Cellular Virology Laboratory, Center for Infection and Immunity of Lille, University Lille Nord de France, CNRS UMR8204, INSERM U1019, Pasteur Institute of Lille, Lille, France.

Virology Department, EA4294 UPJV, Amiens University Hospital, Amiens, France.

出版信息

J Virol. 2015 Aug;89(16):8346-64. doi: 10.1128/JVI.00192-15. Epub 2015 Jun 3.

DOI:10.1128/JVI.00192-15
PMID:26041282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4524216/
Abstract

UNLABELLED

In our study, we characterized the effect of monensin, an ionophore that is known to raise the intracellular pH, on the hepatitis C virus (HCV) life cycle. We showed that monensin inhibits HCV entry in a pangenotypic and dose-dependent manner. Monensin induces an alkalization of intracellular organelles, leading to an inhibition of the fusion step between viral and cellular membranes. Interestingly, we demonstrated that HCV cell-to-cell transmission is dependent on the vesicular pH. Using the selective pressure of monensin, we selected a monensin-resistant virus which has evolved to use a new entry route that is partially pH and clathrin independent. Characterization of this mutant led to the identification of two mutations in envelope proteins, the Y297H mutation in E1 and the I399T mutation in hypervariable region 1 (HVR1) of E2, which confer resistance to monensin and thus allow HCV to use a pH-independent entry route. Interestingly, the I399T mutation introduces an N-glycosylation site within HVR1 and increases the density of virions and their sensitivity to neutralization with anti-apolipoprotein E (anti-ApoE) antibodies, suggesting that this mutation likely induces conformational changes in HVR1 that in turn modulate the association with ApoE. Strikingly, the I399T mutation dramatically reduces HCV cell-to-cell spread. In summary, we identified a mutation in HVR1 that overcomes the vesicular pH dependence, modifies the biophysical properties of particles, and drastically reduces cell-to-cell transmission, indicating that the regulation by HVR1 of particle association with ApoE might control the pH dependence of cell-free and cell-to-cell transmission. Thus, HVR1 and ApoE are critical regulators of HCV propagation.

IMPORTANCE

Although several cell surface proteins have been identified as entry factors for hepatitis C virus (HCV), the precise mechanisms regulating its transmission to hepatic cells are still unclear. In our study, we used monensin A, an ionophore that is known to raise the intracellular pH, and demonstrated that cell-free and cell-to-cell transmission pathways are both pH-dependent processes. We generated monensin-resistant viruses that displayed different entry routes and biophysical properties. Thanks to these mutants, we highlighted the importance of hypervariable region 1 (HVR1) of the E2 envelope protein for the association of particles with apolipoprotein E, which in turn might control the pH dependency of cell-free and cell-to-cell transmission.

摘要

未标注

在我们的研究中,我们描述了莫能菌素(一种已知可提高细胞内pH值的离子载体)对丙型肝炎病毒(HCV)生命周期的影响。我们发现莫能菌素以泛基因型和剂量依赖性方式抑制HCV进入。莫能菌素诱导细胞内细胞器碱化,导致病毒膜与细胞膜之间融合步骤受到抑制。有趣的是,我们证明HCV细胞间传播依赖于囊泡pH值。利用莫能菌素的选择压力,我们筛选出一种对莫能菌素耐药的病毒,该病毒已进化出使用一种部分不依赖pH值和网格蛋白的新进入途径。对该突变体的特征分析导致在包膜蛋白中鉴定出两个突变,E1中的Y297H突变和E2高变区1(HVR1)中的I399T突变,这赋予了对莫能菌素的抗性,从而使HCV能够使用不依赖pH值的进入途径。有趣的是,I399T突变在HVR1内引入了一个N-糖基化位点,并增加了病毒粒子的密度及其对抗载脂蛋白E(抗ApoE)抗体中和的敏感性,这表明该突变可能诱导HVR1中的构象变化,进而调节与ApoE的结合。引人注目的是,I399T突变显著降低了HCV细胞间传播。总之,我们在HVR1中鉴定出一个突变,该突变克服了囊泡pH值依赖性,改变了病毒粒子的生物物理特性,并大幅降低了细胞间传播,表明HVR1对病毒粒子与ApoE结合的调节可能控制游离病毒和细胞间传播的pH值依赖性。因此,HVR1和ApoE是HCV传播的关键调节因子。

重要性

尽管已鉴定出几种细胞表面蛋白作为丙型肝炎病毒(HCV)的进入因子,但其向肝细胞传播的精确调控机制仍不清楚。在我们的研究中,我们使用了莫能菌素A(一种已知可提高细胞内pH值的离子载体),并证明游离病毒和细胞间传播途径都是依赖pH值的过程。我们产生了具有不同进入途径和生物物理特性的莫能菌素耐药病毒。借助这些突变体,我们强调了E2包膜蛋白高变区1(HVR1)对于病毒粒子与载脂蛋白E结合的重要性,这反过来可能控制游离病毒和细胞间传播的pH值依赖性。

相似文献

1
New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.利用离子载体莫能菌素A对丙型肝炎病毒进入及细胞间传播的新认识
J Virol. 2015 Aug;89(16):8346-64. doi: 10.1128/JVI.00192-15. Epub 2015 Jun 3.
2
Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus.高变区 1 缺失和必需的适应性包膜突变赋予丙型肝炎病毒对清道夫受体 B 类 I 和低密度脂蛋白受体的依赖性降低。
J Virol. 2014 Feb;88(3):1725-39. doi: 10.1128/JVI.02017-13. Epub 2013 Nov 20.
3
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.高变区1在丙型肝炎病毒与进入因子及脂蛋白相互作用中的作用。
J Virol. 2014 Nov;88(21):12644-55. doi: 10.1128/JVI.01145-14. Epub 2014 Aug 20.
4
Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.丙型肝炎病毒包膜糖蛋白E1在病毒进入和组装中的新功能鉴定
J Virol. 2017 Mar 29;91(8). doi: 10.1128/JVI.00048-17. Print 2017 Apr 15.
5
Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.丙型肝炎病毒逃逸研究的人抗体 AR3A 揭示了高耐药屏障和病毒抗体逃逸机制的新见解。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01909-18. Print 2019 Feb 15.
6
Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.丙型肝炎病毒包膜糖蛋白E2高变区1中的碱性残基有助于病毒进入。
J Virol. 2005 Dec;79(24):15331-41. doi: 10.1128/JVI.79.24.15331-15341.2005.
7
Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.一种新型苯并咪唑衍生物作为抗丙型肝炎病毒药物的鉴定
J Virol. 2016 Sep 12;90(19):8422-34. doi: 10.1128/JVI.00404-16. Print 2016 Oct 1.
8
Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.丙型肝炎病毒高变区 1(HVR1)中的三个不同功能的微区介导进入和免疫逃逸。
J Biol Chem. 2012 Oct 12;287(42):35631-35645. doi: 10.1074/jbc.M112.382341. Epub 2012 Aug 27.
9
Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization.高变区 1 对基因型 1 至 6 的丙型肝炎病毒株的存活能力有不同影响,并损害病毒中和作用。
J Virol. 2011 Mar;85(5):2224-34. doi: 10.1128/JVI.01594-10. Epub 2010 Dec 1.
10
Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.针对E2和高变区1的鼠源抗体可交叉反应性捕获丙型肝炎病毒。
Virology. 1998 Nov 10;251(1):158-64. doi: 10.1006/viro.1998.9393.

引用本文的文献

1
Protons to Patients: targeting endosomal Na /H exchangers against COVID-19 and other viral diseases.质子疗法:针对 COVID-19 和其他病毒疾病的内体 Na+/H+交换体的靶向治疗。
FEBS J. 2021 Sep;288(17):5071-5088. doi: 10.1111/febs.16163.
2
Hepatitis C Virus Glycan-Dependent Interactions and the Potential for Novel Preventative Strategies.丙型肝炎病毒糖基依赖性相互作用及新型预防策略的潜力
Pathogens. 2021 Jun 1;10(6):685. doi: 10.3390/pathogens10060685.
3
HCV Interplay with Lipoproteins: Inside or Outside the Cells?HCV 与脂蛋白的相互作用:在细胞内还是细胞外?
Viruses. 2020 Apr 12;12(4):434. doi: 10.3390/v12040434.
4
Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.糖基掩蔽与丙型肝炎病毒中和抗体的调节。
Front Immunol. 2018 Apr 27;9:910. doi: 10.3389/fimmu.2018.00910. eCollection 2018.
5
A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.一种新型抑制剂 IDPP 通过靶向 HCV 糖蛋白 E1 以基因型特异性方式干扰 HCV 的进入和输出。
Sci Rep. 2017 Mar 23;7:44676. doi: 10.1038/srep44676.
6
Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.通过病毒感染激活的分裂内含肽介导的报告系统,可视化完整病毒体组装机制在丙型肝炎病毒细胞间高效传播中的重要作用。
J Virol. 2017 Jan 3;91(2). doi: 10.1128/JVI.01720-16. Print 2017 Jan 15.
7
Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.一种新型苯并咪唑衍生物作为抗丙型肝炎病毒药物的鉴定
J Virol. 2016 Sep 12;90(19):8422-34. doi: 10.1128/JVI.00404-16. Print 2016 Oct 1.
8
Release of Infectious Hepatitis C Virus from Huh7 Cells Occurs via a trans-Golgi Network-to-Endosome Pathway Independent of Very-Low-Density Lipoprotein Secretion.丙型肝炎病毒从Huh7细胞的释放通过一条独立于极低密度脂蛋白分泌的从反式高尔基体网络到内体的途径发生。
J Virol. 2016 Jul 27;90(16):7159-70. doi: 10.1128/JVI.00826-16. Print 2016 Aug 15.
9
Fusion of Enveloped Viruses in Endosomes.包膜病毒在内体中的融合
Traffic. 2016 Jun;17(6):593-614. doi: 10.1111/tra.12389. Epub 2016 Apr 7.
10
(+)-Catechin inhibition of transmissible gastroenteritis coronavirus in swine testicular cells is involved its antioxidation.(+)-儿茶素对猪睾丸细胞中传染性胃肠炎冠状病毒的抑制作用涉及其抗氧化作用。
Res Vet Sci. 2015 Dec;103:28-33. doi: 10.1016/j.rvsc.2015.09.009. Epub 2015 Sep 12.

本文引用的文献

1
Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.丙型肝炎病毒与硫酸乙酰肝素蛋白聚糖相互作用的表征
J Virol. 2015 Apr;89(7):3846-58. doi: 10.1128/JVI.03647-14. Epub 2015 Jan 21.
2
A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.预防性丙型肝炎病毒疫苗:仍值得攀登的遥远高峰。
J Hepatol. 2014 Nov;61(1 Suppl):S34-44. doi: 10.1016/j.jhep.2014.09.009. Epub 2014 Nov 3.
3
Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90.丙型肝炎感染患者的外泌体可传播HCV感染,并含有与Ago2-miR122-HSP90复合的具有复制能力的病毒RNA。
PLoS Pathog. 2014 Oct 2;10(10):e1004424. doi: 10.1371/journal.ppat.1004424. eCollection 2014 Oct.
4
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.高变区1在丙型肝炎病毒与进入因子及脂蛋白相互作用中的作用。
J Virol. 2014 Nov;88(21):12644-55. doi: 10.1128/JVI.01145-14. Epub 2014 Aug 20.
5
Alternative endocytosis pathway for productive entry of hepatitis C virus.丙型肝炎病毒有效进入的替代性内吞途径。
J Gen Virol. 2014 Dec;95(Pt 12):2658-2667. doi: 10.1099/vir.0.068528-0. Epub 2014 Aug 5.
6
Curing chronic hepatitis C--the arc of a medical triumph.治愈慢性丙型肝炎——医学胜利之路
N Engl J Med. 2014 Apr 24;370(17):1576-8. doi: 10.1056/NEJMp1400986. Epub 2014 Apr 10.
7
New hepatitis C therapies: the toolbox, strategies, and challenges.新型丙型肝炎治疗方法:工具包、策略和挑战。
Gastroenterology. 2014 May;146(5):1176-92. doi: 10.1053/j.gastro.2014.03.003. Epub 2014 Mar 12.
8
Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2.丙型肝炎病毒包膜糖蛋白 2 核心外域结构。
Nature. 2014 May 15;509(7500):381-4. doi: 10.1038/nature13117. Epub 2014 Feb 19.
9
CD81 and hepatitis C virus (HCV) infection.CD81 与丙型肝炎病毒(HCV)感染。
Viruses. 2014 Feb 6;6(2):535-72. doi: 10.3390/v6020535.
10
Hepatitis C virus E2 envelope glycoprotein core structure.丙型肝炎病毒 E2 包膜糖蛋白核心结构。
Science. 2013 Nov 29;342(6162):1090-4. doi: 10.1126/science.1243876.